Breast Cancer Trial, Recruiting NCT07228000 Sponsor: Georgetown University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07228000
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are seeking cancer screening navigation services through a program at one of the two participating centres: Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center & Research Institute
  • People who are due for both breast cancer screening and colorectal cancer screening, based on guidelines from the U.S. Preventive Services Task Force (USPSTF)
  • People who are female
  • People aged 45 to 74
  • People who identify as Black/African American and/or Hispanic/Latina/Latine
  • People who speak English or Spanish well enough to take part in study activities
  • People who are willing and available to take part in all study activities — including navigation sessions and surveys — for the full length of the study
  • People who are able to provide their own electronic consent to participate

Who may not be able to join:

  • People who are not currently using or planning to use navigation programs at the two participating centres listed above
  • People who are not due for breast cancer screening or colorectal cancer screening based on USPSTF guidelines
  • People who have a personal history of breast cancer and/or colorectal cancer, or who are currently experiencing symptoms that may be related to these cancers (such as gastrointestinal bleeding or a breast lump)
  • People who are male, intersex, or of another sex
  • People who are under 45 or over 74 years of age
  • People who do not identify as Black/African American or Hispanic/Latina/Latine
  • People who do not speak English or Spanish with enough fluency to complete study activities
  • People who are unwilling or unable to commit to taking part in all study activities for the full duration of the study
  • People who are unable to provide their own electronic consent, or who would need another person to provide consent on their behalf

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 202-687-0869

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Georgetown University
Registry
ClinicalTrials.gov
Start date
6 May 2026
Est. completion
28 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Receipt of colorectal cancer screening; Receipt of breast cancer screening

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov